Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187160 | SCV000240738 | likely benign | not specified | 2017-11-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000187160 | SCV000333208 | likely benign | not specified | 2015-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460589 | SCV000563229 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000187160 | SCV000594186 | likely benign | not specified | 2015-10-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311264 | SCV000847247 | likely benign | Inborn genetic diseases | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003311709 | SCV004010735 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | CNTNAP2: BP4, BS2 |
Breakthrough Genomics, |
RCV003311709 | SCV005219807 | likely benign | not provided | criteria provided, single submitter | not provided |